Carnick & Kubik Group LLC decreased its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,952 shares of the pharmacy operator’s stock after selling 939 shares during the quarter. Carnick & Kubik Group LLC’s holdings in Walgreens Boots Alliance were worth $2,403,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. Comerica Securities Inc. grew its holdings in Walgreens Boots Alliance by 23.7% during the 4th quarter. Comerica Securities Inc. now owns 16,457 shares of the pharmacy operator’s stock valued at $1,124,000 after purchasing an additional 3,154 shares during the last quarter. Geode Capital Management LLC boosted its position in Walgreens Boots Alliance by 7.8% in the 4th quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock valued at $786,522,000 after buying an additional 834,241 shares during the period. Capital Investment Advisors LLC boosted its position in Walgreens Boots Alliance by 38.5% in the 1st quarter. Capital Investment Advisors LLC now owns 8,442 shares of the pharmacy operator’s stock valued at $534,000 after buying an additional 2,348 shares during the period. Valeo Financial Advisors LLC boosted its position in Walgreens Boots Alliance by 20.7% in the 1st quarter. Valeo Financial Advisors LLC now owns 2,904 shares of the pharmacy operator’s stock valued at $184,000 after buying an additional 499 shares during the period. Finally, Truvestments Capital LLC purchased a new stake in Walgreens Boots Alliance in the 1st quarter valued at about $312,000. 62.12% of the stock is owned by institutional investors.
Several research firms have issued reports on WBA. BidaskClub cut shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Monday, June 24th. Zacks Investment Research cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price objective for the company. in a research report on Monday, June 10th. Bank of America lowered their price objective on shares of Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a research report on Monday, June 3rd. JPMorgan Chase & Co. lowered their price objective on shares of Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a research report on Friday, June 28th. Finally, Morgan Stanley set a $61.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Tuesday, May 14th. Six investment analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $63.82.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a net margin of 3.53% and a return on equity of 22.08%. The firm had revenue of $34.59 billion during the quarter, compared to analysts’ expectations of $34.52 billion. During the same quarter in the prior year, the company earned $1.53 EPS. The company’s revenue was up .7% compared to the same quarter last year. On average, equities analysts expect that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Tuesday, August 20th will be given a $0.458 dividend. This represents a $1.83 annualized dividend and a dividend yield of 3.47%. The ex-dividend date of this dividend is Monday, August 19th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. Walgreens Boots Alliance’s dividend payout ratio is presently 29.24%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Dead Cat Bounce
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.